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Neurocognitive impairment (NCI) among high-risk substance users poses a substantial 
barrier to reducing risk behaviors in this population. Previous work suggests that NCI is 
intertwined in a close, reciprocal relationship with risk behaviors. Not only does substance 
use worsen cognitive impairment but cognitive impairment may also reduce the efficacy 
of interventions aimed at reducing risk and improving medication adherence. In this 
systematic review, we examine the potential impact of substance abuse and cognitive 
functioning in the context of HIV risk behaviors and risk-reduction intervention outcomes. 
The findings thus far suggest that, in order to be effective, risk-reduction interventions 
must take into account the impact of NCI on learning, memory, and behavior.
Keywords: neurocognitive impairment, substance abuse, Hiv risk behaviors, systematic review, Hiv/AiDS, 
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iNTRODUCTiON
Since the beginning of the HIV/AIDS epidemic, approximately 600,000 people have died of AIDS-
related illnesses in the United States alone. Despite a wide array of preventive measures, the US is 
still facing a continuing epidemic, with approximately 50,000 new infections per year (1). Substance 
use – including alcohol, injection drug use (IDU), and non-IDU – remains an important risk factors 
fueling the epidemic. Although the number of new HIV infections attributed to IDU has declined 
significantly over time, rates continue to be high among specific sub-populations, including racial/
ethnic minority groups (2). Beyond risk from injection-related behaviors (e.g., sharing needles), use 
of illicit drugs is an important driver of sexual transmission of HIV. Previous research has found that 
substance users engage in high-risk sexual behavior, including trading sex for drugs or money (3–5), 
having multiple sex partners (6–8), and unprotected intercourse (7–9). Therefore, there is an urgent 
need for interventions targeting substance use-related behavioral changes in order to reduce rate of 
HIV incidence in this population.
Recent studies exploring the effects of substance use on the brain have demonstrated a variety 
of adverse effects on the central nervous system (CNS) resulting in neurocognitive impairment 
(NCI) symptoms (10–14). Indeed, studies have shown an extensive overlap between the brain 
regions and neural processes involved in substance addiction and those that are known to be of 
FiGURe 1 | Summary of study selection process.
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relevance for cognitive functions like learning, memory, and 
reasoning. The repeated exposure to abusive drugs produces 
significant structural and functional abnormalities in the brain, 
predominantly in the frontal cortex and temporal lobe, areas 
considered crucial for executive control (15–21). This cognitive 
shift, followed by continued substance abuse, may play a role in 
the development of addiction and exacerbate the difficulty of 
sustaining abstinence.
Substance abuse and the presence of neurocognitive deficits 
are independently associated with increased drug- and sex-
related risk behaviors and HIV intervention outcomes in studies 
that have examined high-risk HIV substance using samples 
(3–9, 22–25). Some research has suggested synergistic deleterious 
impacts of substance use and NCI on HIV-related risk behaviors 
(24, 26). Importantly, the impairment in cognitive functioning 
influenced by continued substance use among substance abusers 
may also prevent normal acquisition and retention of intervention 
content delivered through behavioral risk-reduction intervention 
approaches (22, 27, 28). Thus, understanding the relationship 
between substance abuse, NCI, and HIV risk factors is crucial to 
successfully intervening against a range of risk behaviors among 
substance abusers. This systematic review is aimed at exploring 
the relevant research literature to more clearly examine the possi-
ble impact of NCI on HIV risk as well as HIV intervention efforts 
targeting high-risk HIV substance users.
MeTHODS
Search Methods for identification of 
Studies
The literature review was restricted to peer-reviewed original 
human research articles and dissertations that focused on 
the effects of cognitive functioning on HIV risk behaviors. 
Searches included relevant English language papers published 
in 1981–2014. Relevant studies were located using several search 
strategies. First, PubMed, ProQuest Dissertations, and Theses 
were searched using Boolean operators:: {[(HIV risk behaviors) 
OR (sexual risk behaviors) OR (substance abuse risk behavior) 
OR (drug abuse risk behavior) OR (needle shar*) OR (condom 
use) OR (HIV knowledge)] AND [(neuropsychol*) OR (cogni-
tive deficit) OR (neurocognitive disorder) OR (neurocog*) OR 
(executive function) OR (attention deficit) OR (memory deficit) 
OR (HIV-associated neurocognitive disorders) OR (visual motor 
function) OR (spatial problem solving) OR (psychomotor func-
tion) OR (speed of processing) OR (visual attention) OR (visual 
learning) OR (working memory deficit) OR (social cognition)] 
AND [(substance use*) OR (drug use*) OR (drug addict*) OR 
(drug dependent) OR (IDU) OR (injection drug use*) OR (illegal 
drug use*) OR (opiate user) OR (heroine user) OR (street drug 
user)]}. Both a combined text word and Medical Subject Headings 
(MeSH) terms were used to identify relevant papers. Second, 
a secondary search was conducted that involved checking the 
reference sections of relevant review papers and google scholar 
for articles that may have been missed in the initial computerized 
search.
Study Selection and inclusion/exclusion 
Criteria
In conducting this systematic review, peer-reviewed studies were 
included if they met all of the following criteria: (a) participants 
were high-risk substance users; (b) assessed participants’ NCI 
status; (c) assessed substance- or sexual-related HIV risk behav-
ior outcome(s); and (d) were published in English. The search 
was not limited to any particular geographic area or region, and 
there were no restrictions imposed on the age of subject popula-
tions. Studies were excluded if they focused on sexual and drug 
use transmission risk but not on cognitive impairment. We also 
excluded pharmaceutical studies.
A total of 140 articles were retrieved as of September, 2015. 
After nine additional articles were found in the reference section 
of the relevant journal articles, we had 148 articles for preliminary 
review. Of these, 14 were subsequently excluded because they 
were either review articles (4), were not human studies (7), and 
non-English articles (3), leaving 135 records for further review 
(Figure 1). After inspecting study titles and abstracts, we found 
that 107 records were not directly relevant to the study objectives 
(98), described ongoing studies with no data published (1) or 
lacked the stated outcomes of interest (8), leaving 28 records for 
further, more detailed, review. A full-text copy of this subset of 
studies was obtained and assessed for inclusion. Nineteen full-
text records were excluded because they did not investigate the 
variables of interest. Thus, a total of nine studies were included 
for this review (Figure 1).
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Data extraction and Management
Data concerning study characteristics, participant characteristics, 
study design characteristics, and outcome characteristics were 
independently abstracted from relevant studies by two trained 
reviewers (Roman Shrestha and Michael Copenhaver). Any 
discrepancies were resolved by discussion.
A standardized form was used for data extraction. Article 
characteristics included such dimensions as (a) authors, (b) year 
of publication, (c) year of data collection, (d) sample size, (e) loca-
tion of study, and (f) whether a theoretical framework guided 
the interventional design, if applicable. Participant characteristics 
included (a) age, (b) race/ethnicity, (c) gender distribution of 
participants, and (d) sample type. Study design characteristics 
included (a) type of study design (e.g., randomized controlled 
trial), (b) type of control group, and (c) type of neurocognitive 
deficit measure. Outcome characteristics included influence of 
NCI on HIV risk behaviors, including (a) knowledge about HIV, 
(b) motivation to change behaviors, (c) self-reported condom use 
(male or female condoms), (d) self-reported number of sexual 
partners, (e) self-reported IDU pattern, and (f) self-efficacy 
(assessing self-confidence related to condom application skills, 
sexual practices, and needle cleaning skills after intervention).
ReSULTS
Description of Studies
A total of nine studies met the review inclusion criteria (Table 1). 
Studies were conducted between 1999 and 2014, with the majority 
(77.8%) taking place within the past decade (2004–2014). In terms 
of methods, over one-third of the studies (33.3%) were cross- 
sectional, 33.3% longitudinal, 22.2% were randomized controlled 
trial, and 11.1% were case–control. Studies collected data through 
face-to-face interviews (66.6%) or self-administered surveys 
(33.3%). Seventy-seven percent (k = 7) of the studies mentioned 
the specific measure used to assess neurocognitive deficit of the 
participants, whereas 22.2% (k = 2) did not. HIV-related knowledge 
among samples was assessed in two studies (22.2%), motivation to 
change risk behaviors in two studies (22.2%) and self-efficacy in two 
studies (22.2%). Sexual risk was measured in terms of unprotected 
sex in seven studies (77.8%), condom use in seven studies (77.8%), 
and having multiple sexual partners in two studies (22.2%).
Overall, 1,836 substance users were enrolled across the study. 
Study sample sizes ranged from 51 to 579, with the average 
number of 204 per study. The average age across samples was 
36.8 years (range = 15.8–49.3; k = 9). Study participants were all 
HIV-negative substance users randomly recruited from venues 
that served active substance users, including substance abuse 
treatment clinics, service organizations, or defined communities. 
Less than half (44.4%) of the studies provided monetary incen-
tives for study participation. A complete summary of the outcome 
measures generated from each citation appears in Table 1. The 
results by outcome were as follows.
Neurocognitive impairment and its 
influence on Hiv Risk Behaviors
The majority of the studies reviewed in the present study found a 
significant association between a higher level of NCI and a greater 
level of HIV-related risk behaviors among substance users. A 
recent study by Worley et al. on the effects of NCI on substance 
uses among adults in treatment for alcohol or drug dependence 
found that more severe NCI predicted poorer alcohol and drug 
use outcomes via lower self-efficacy (i.e., confidence to resist use 
of alcohol or drugs across a variety of high-risk situations) (28). 
Interestingly, among a sample of heroin IDUs who were HIV-
seronegative, aged between 18 and 30 years, Mitchell et al. found 
that cognitive performance had a moderating effect on IDU 
behaviors, such as individuals who had lower cognitive scores 
and knew someone who had died from AIDS were more likely to 
report higher-risk injection behavior (i.e., shared needles or used 
the same cooker, cotton, or rinse water) (32).
In a longitudinal study, Stacy et  al. showed that implicit 
cognition indicator, which refers to the learning, memory, and 
performance processes, which take place without the subject’s 
conscious awareness, was an independent predictor of lack 
of condom use in a high-risk sample (33). Implicit cognition 
predicted unprotected sex in this sample even when other poten-
tially strong predictors were controlled (e.g., drug use, sensation 
 seeking) (33). Likewise, Schuster et  al. found both direct and 
indirect associations between aspects of inhibitory control and 
risky sexual behaviors (RSBs) (25). The same study also found 
that the amount of recent cannabis use was associated with over-
all sexual-risk, as expected. The relationship between amount of 
recent cannabis use and overall RSBs, however, was moderated by 
performance on decision-making, with significant relationships 
emerging only among those who performed more poorly. This 
supports the notion that neurocognitive functioning, particularly 
in the domains of risk-taking and episodic memory, may influ-
ence the degree to which cannabis users engage in RSBs (25).
More recently, Albein-Urios et  al. compared the cognitive 
performance of cocaine-dependent individuals (CDI) with that 
of pathological gamblers (PG) (29). The study found that CDI, as 
compared to PG, had elevated scores on Negative Urgency and 
poorer performance on working memory. Correlational analyses 
showed significant negative associations between performance 
on the working memory and response inhibition tasks and peak 
amount of cocaine use (29). The finding of this study that cocaine 
dependence is specifically associated with working memory 
deficits is in agreement with our hypothesis.
Although the vast majority of studies reported some degree of 
influence of NCI on HIV-related risk behaviors, we also identified 
studies that suggested otherwise. For example, a cross-sectional 
study among poly-drug users from the Chicago metropolitan 
area, seeking services from various community clinics, did not 
find any significant relationships between neurocognitive per-
formance and self-reported risky sexual practices for the overall 
subject sample (23). Also, Black et al. reported similar findings 
among psychiatric outpatients with a comorbid substance abuse 
dependence disorder in a community mental health center in 
Connecticut, USA. They reported that cognitive impulsivity was 
not found to have a significant correlation with any RSBs (30).
Furthermore, similar finding has been found among a sam-
ple of IDUs in New York City who are infected with HIV. In a 
longitudinal study, Dolezal et al. found no significant association 
between neurological assessment outcomes and any of the risk 
February 2016 | Volum




















TABLe 1 | Summary of studies included in the systematic review.




Granada, Spain Substance Abuse 
Treatment Clinic
72 NR NR Cocaine dependent vs. 
pathological gamblers
Case–control Peak amount of cocaine use was negatively correlated with 
working memory and response inhibition performance.




51 31 20 Substance dependent Cross-sectional Rash-spontaneous impulsivity was not associated with risky 
sexual behaviors
Dolezal et al. (31) New York, USA HIV Center for 
Clinical and 
Behavioral Studies
144 0 144 IDU Longitudinal Presence of HIV-related symptoms and neuropsychological 
impairment were associated with lower sexual risk. 
Neurological impairment and depression were not 
associated with sexual risk behavior
Gonzalez et al. (23) Chicago, USA Chicago 
Metropolitan Area
263 NR NR HIV+ and HIV-substance 
dependent individuals
Cross-sectional Continued risk behavior among HIV+ drug users may be 
driven by sensation seeking (a personality trait common 
among drug users); however, the impact of executive 
functions is less clear




229 78 151 IDU Longitudinal African American IDUs, especially those with lower cognitive 
functioning, compared with White IDUs, were less likely 
to share drugs and other injection equipment; Cognitive 
performance moderated the effect of knowing someone who 
had died from AIDS on engaging in risky injection drug use 
behaviors, such that individuals who had lower cognitive 
scores and knew someone who had died from AIDS were 





Methadone Clinic 280 151 129 HIV-individuals opioid 
dependent drug users 
receiving MMT
RCT Participants with lower levels of NCI who specifically 
receive the CHRP intervention demonstrate more HIV risk 
reduction skill development while, less improvement from the 
intervention content was seen among the intervention group 
participants with higher levels of NCI
Schuster et al. (25) Chicago, USA Chicago 
Metropolitan Area
66 25 41 Cannabis users Cross-sectional Contrary to hypotheses, worse episodic memory also 
significantly predicted higher overall sexual-risk and 
decreased safe-sex practices
Stacy et al. (33) California, USA Junior High School 579 NR NR Men and women in Los 
Angeles County
Longitudinal Memory association predicted unprotected sex in the 
high-risk but not the low-risk sample The implicit cognition 
measure used in the present study predicted unprotected 
sex in this sample even when other potentially strong 
predictors were controlled for in the analysis (e.g., drug use, 
sensation seeking)




197 19 178 Veterans receiving 
treatment for AODD  
and MDD
RCT More severe baseline NCI predicted poorer alcohol and drug 
use outcomes via lower self-efficacy, lower 12-step affiliation, 
& greater depressive symptoms
NR, not reported.
February 2016 | Volume 4 | Article 165
Shrestha and Copenhaver Neurocognitive Impairment and HIV Risk Behaviors
Frontiers in Public Health | www.frontiersin.org
behaviors, including less unprotected sex, abstinence, and lower 
risk index scores. Lower scores on the Selective Reminding Test, 
however, were associated with abstinence and lower risk index 
scores (31).
Neurocognitive impairment and its 
influence on intervention Outcomes
Researchers recently explored the association between NCI and 
risk reduction intervention outcomes among chronic substance 
users participating in methadone-maintained drug treatment 
(27). Following the intervention, improvements in treatment 
outcomes were negatively associated with NCI among the study 
participants. This finding showed that participants with higher 
levels of neurocognitive deficits demonstrated lesser HIV risk 
reduction skills development compared with participants with 
lower levels of NCI. The same study also found that higher degree 
of NCI was associated with lower self-efficacy about sex-risk 
reduction behavior (i.e., purchasing condoms) as well as more 
difficulty learning HIV risk reduction skills (i.e., needle cleaning 
skills) (27).
DiSCUSSiON
We reviewed studies that included data on the influence of NCI on 
HIV risk behaviors and intervention outcomes among high-risk 
substance users. Consistent with our hypotheses, we found both 
direct and indirect associations between NCI and risk behaviors 
and intervention outcomes (25, 27–29, 32, 33). The nature of 
findings linked to neurocognitive deficits suggests that this may 
negatively influence risk-taking behavior. For example, impaired 
executive function impedes rational decision-makingwhich may 
prevent individuals from making safe sexual choices. Similarly, 
slowed information processing function may prevent the timely, 
appropriate consideration of risk variables during decision-
making instances (34).
Neurocognitive impairment may also play a substantial role in 
how drug dependent individuals respond to HIV interventions 
(27, 28). Traditional “behavioral” HIV prevention strategies tend 
to place a high demand on numerous cognitive abilities such as 
attention, learning, memory, and information processing (35). As 
such, neurocognitive deficits may function as a confounding vari-
able with regard to a range of intervention outcomes. Moderate 
levels of impairment that is common among substance users may 
impede the presumed attainment and retention of behavioral 
content provided in traditional intervention and treatment pro-
grams (34).
Our results support the notion that cognitive functioning, par-
ticularly in the domains of executive function, decision-making, 
working memory, and cognitive impulsivity, may influence the 
degree to which substance users engage in risky behaviors (3, 
7, 23, 25, 27). Importantly, these findings persisted even after 
accounting for confounding variables (e.g., substance use), sug-
gesting that the relationships between neurocognitive function-
ing and risk behaviors are not simply due to severity of substance 
use. Some results, however, also indicate that the presence of 
NCI may not confer increased risk behavior universally. Instead, 
the contribution of cognitive deficits on risk behavior may vary 
across ethnicities and/or geographic location, socioeconomic 
status, gender, and sexual orientation, thus precluding universal 
generalizations, as might be expected (23, 30, 31).
Some of the limitations of this systematic review should be 
acknowledged. First, the review of articles was restricted to 
peer-reviewed journal articles published in English. This may 
have likely biased our selection of articles toward predominantly 
English-speaking countries. In addition, we initially screened only 
abstracts to determine whether the study investigated the impact 
of cognitive deficits on HIV risk behavior outcomes. Thus, any 
secondary outcomes and analyses pertinent to our areas of inter-
est not mentioned within the abstracts may have been excluded 
from this review. Many risk behaviors were self-reported by the 
study participants, often at much later time points, making their 
response open to bias and social desirability factors. In addition, 
due to a reliance on primarily cross-sectional study designs, it is 
not possible to drawn causal inferences regarding the independ-
ent influence of NCI.
CONCLUSiON AND FUTURe DiReCTiONS
The findings of this study indicate that the majority of the available 
research has shown a close and reciprocal association between 
NCI and increased HIV risk behaviors among high-risk substance 
users. The literature also suggested that NCI is associated with 
how well these same risk individuals respond to interventions 
aimed at reducing risk behaviors. The findings from this review 
suggest that more attention needs to be given to screening for 
NCI among this population, and appropriately accommodating 
them in the delivery of HIV risk-reduction interventions. Though 
untested to date, previous reviews have suggested that behavioral 
HIV prevention strategies integrating cognitive remediation 
strategies, multi-modal presentation of information, and a focus 
on real-world applications may be useful when incorporated 
into behavioral risk reduction strategies among individuals with 
cognitive deficits (34). As such, future studies should examine the 
feasibility and direct impact of incorporating specific behavioral 
intervention strategies designed to accommodate the moderate 
levels of NCI – thus allowing greater potential benefit – among 
high-risk substance users.
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